Getting Ready for the Age of Biogenerics | SupplyChainBrain
Shankar Suryanarayanan Icon

A new wave of generic drugs will have major implications for pharmaceutical supply chains, says Shankar Suryanarayanan, co-chairman of the Biotech Supply Chain Academy. [Run Time (Min:) 7:48]


Viewthe Video Button 01

Related Content

Related Videos

Featured Product

More in All Logistics
Page 1 of 957
Next Page

Visit Our Sponsors